Donate

News

Latest news

Sir Sam Neil joins the growing call for access to standard blood cancer treatments

September 6, 2023

Rodger Tiedemann: The cancer treatments you need are available, just not in NZ

September 6, 2023

Father of two who’s spent his life serving the public told to consider Australia for funded cancer treatment

August 14, 2023,

Bitter pill: New report finds NZ lags behind in timely access to medicines

August 10, 2023,

Jacq Dwyer Myeloma NZ advocate shares her story

July 9, 2023,

Warmest congratulations to Dr Ruth Spearing CNZM

June 7, 2023

NZ’s Shameful Health Secret

May 17, 2023

15 year cancer thriver rides around New Zealand raising money and awareness for blood cancer multiple myeloma

May 4, 2023

Time taken for Pharmac funding decisions ‘too long’, says Medicines NZ

April 27, 2023

Cancer patients harmed by ongoing treatment delays at Southern health board

April 12, 2023,

Therapeutic Products Bill Submission!

March 31, 2023,

In Focus: From the lab to the clinic in New Zealand’s first CAR T-cell therapy clinical trial

March 9, 2023

Dr Ken Romeril, Multiple Myeloma founder, Member of the NZ Order of Merit, advocates for the desperate need for access to modern medicines for myeloma sufferers.

December 11, 2022

BLOOD CANCER PATIENTS IMPLORE PHARMAC TO FUND DESPERATELY NEEDED MEDICINE

September 7, 2022

Multiple Myeloma Research Review

August 23, 2022, , ,

Newsletter: Winter 2022

August 22, 2022

Rachel Smalley: 1,000 kiwis will die while Pharmac takes eight months to make a decision

August 17, 2022, ,

Multiple Myeloma Queenstown Summit

June 29, 2022, ,

Multiple Myeloma Research Review

May 23, 2022, , ,

Multiple Myeloma CEO, Dr Ken Romeril, on The AM Show this morning, calling for a release of the independent report on Pharmac

May 11, 2022

DOCTOR CALLS ON MINISTER LITTLE TO RELEASE ‘BURIED’ INDEPENDENT REPORT ON PHARMAC

May 11, 2022,

Dr Ken Romeril, of Wellington, receives his MNZM for services to haematology.

May 4, 2022,

Updates on the Rapidly Changing Therapeutic Landscape in Multiple Myeloma

May 1, 2022,

Multiple Myeloma Media Release

April 28, 2022,

Decision on access criteria for oral COVID-19 treatments

April 24, 2022,

FRAIL-M TRIALS FOR TRANSPLANT INELIGIBLE MYELOMA (PHASE I/II)

April 19, 2022, ,

Honoured haematologist and HIV pioneer fears he won’t see action from ‘glacial’ Pharmac in his lifetime.

April 10, 2022,

COVID-19 information for patients and whānau with cancer.

March 25, 2022,

Pharmac Review Final Report – Update

March 10, 2022

Newsletter: Autumn 2022

March 6, 2022

Endorsers of the ICBCC Patient Impact Statement

March 3, 2022, ,

Myeloma Australia’s Medical and Scientific Advisory Group (MSAG), article of the week 

February 17, 2022,

CD38 directed therapy shows promise in Multiple Myeloma

February 16, 2022

Australians have limited awareness of blood cancers, – new survey

February 11, 2022,

Which haematology patients are at higher risk of COVID-19?

February 10, 2022, ,

Expert advice on preventing infection in multiple myeloma

February 9, 2022

Dr Ken Romeril – The Medicine Gap

November 29, 2021

Newsletter: Spring 2021

November 29, 2021

Seminar: Treatment of newly diagnosed myeloma – when things don’t go to plan

November 22, 2021

Myeloma NZ End of Year Function

November 22, 2021,

COVID mortality rate a concern in vaccinated blood cancer patients

November 17, 2021,

Proactive fatigue screening and management called for in blood cancer patients

November 10, 2021

Covid-19: ‘Not fair’ unvaccinated will force mum with blood cancer to stay ‘locked’ in home for remaining years

October 29, 2021, ,

New Trial In Relapsed/refractory multiple myeloma

October 28, 2021

Paediatric oncology parents are pleased with quality of care despite pandemic

October 21, 2021, ,

PVd triplet therapy now on PBS for MM patients after first relapse

October 13, 2021,

ATAGI specifies which patients with haematological malignancy should have COVID-19 booster vax

October 13, 2021, ,

‘I am screwed if it comes back’: Experts concerned by Covid’s hidden impact on blood cancer treatments

September 27, 2021, ,

Myeloma Research Review – Issue 39

September 2, 2021,

Newsletter: Winter 2021

August 16, 2021,